RHUMBLINE ADVISERS - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$246,874
-16.0%
228,595
+0.3%
0.00%
Q2 2023$293,965
+99212.5%
227,880
+1.8%
0.00%
Q1 2023$296
-9.5%
223,880
+2.6%
0.00%
Q4 2022$327
-99.9%
218,270
+2.5%
0.00%
Q3 2022$251,000
+16.7%
213,000
+12.0%
0.00%
Q2 2022$215,000
-60.8%
190,166
+3.7%
0.00%
-100.0%
Q1 2022$548,000
+13.5%
183,347
+0.6%
0.00%0.0%
Q4 2021$483,000
-28.3%
182,238
-1.9%
0.00%0.0%
Q3 2021$674,000
-14.5%
185,763
+2.3%
0.00%0.0%
Q2 2021$788,000
+16.7%
181,541
-8.0%
0.00%0.0%
Q1 2021$675,000
-8.4%
197,430
-6.2%
0.00%0.0%
Q4 2020$737,000
+54.8%
210,470
+6.1%
0.00%0.0%
Q3 2020$476,000
+15.0%
198,330
-12.2%
0.00%0.0%
Q2 2020$414,000
+15.0%
226,015
-2.1%
0.00%0.0%
Q1 2020$360,000
-27.9%
230,946
-0.9%
0.00%0.0%
Q4 2019$499,000
+16.6%
232,946
+1.7%
0.00%0.0%
Q3 2019$428,000
-28.2%
229,049
+0.3%
0.00%0.0%
Q2 2019$596,000
+8.8%
228,457
+7.1%
0.00%0.0%
Q1 2019$548,000
+9.2%
213,298
-2.2%
0.00%0.0%
Q4 2018$502,000
+6.6%
218,130
+48.8%
0.00%0.0%
Q3 2018$471,000
+7.0%
146,640
-5.7%
0.00%0.0%
Q2 2018$440,000
-7.2%
155,515
+16.3%
0.00%0.0%
Q1 2018$474,000
+3.3%
133,770
+13.1%
0.00%0.0%
Q4 2017$459,000
+27.5%
118,290
-16.6%
0.00%0.0%
Q3 2017$360,000
-5.8%
141,884
+1.5%
0.00%0.0%
Q2 2017$382,000
-12.6%
139,814
+6.0%
0.00%0.0%
Q1 2017$437,000
+68.1%
131,904
+20.6%
0.00%0.0%
Q4 2016$260,000
-42.4%
109,379
-11.0%
0.00%0.0%
Q3 2016$451,000
+63.4%
122,913
-0.8%
0.00%0.0%
Q2 2016$276,000
+24.9%
123,963
+16.6%
0.00%0.0%
Q1 2016$221,000
-28.7%
106,334
+4.0%
0.00%0.0%
Q4 2015$310,000
+31.9%
102,229
+7.4%
0.00%0.0%
Q3 2015$235,000
-20.1%
95,154
+4.0%
0.00%0.0%
Q2 2015$294,000
-37.6%
91,455
-30.6%
0.00%0.0%
Q1 2015$471,000
+65.8%
131,845
+5.4%
0.00%0.0%
Q4 2014$284,000
+27.4%
125,145
+9.0%
0.00%0.0%
Q3 2014$223,000
-46.5%
114,7700.0%0.00%0.0%
Q2 2014$417,000
-7.7%
114,770
-1.4%
0.00%0.0%
Q1 2014$452,000
+31.8%
116,400
-3.2%
0.00%0.0%
Q4 2013$343,000
-25.1%
120,240
-6.0%
0.00%0.0%
Q3 2013$458,000
+6.5%
127,940
-0.6%
0.00%0.0%
Q2 2013$430,000128,7180.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders